IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v21y2024i3p352-d1357921.html
   My bibliography  Save this article

The Commercial Determinants of Violence: Identifying Opportunities for Violence Prevention through a Public Health-Based Framework Analysis

Author

Listed:
  • Mark A. Bellis

    (Public Health Institute, World Health Organization Collaborating Center for Violence Prevention, Faculty of Health, Liverpool John Moores University, Liverpool L2 2QP, UK)

  • Sally McManus

    (Violence and Society Centre, City, University of London, London EC1V 0HB, UK)

  • Karen Hughes

    (Policy and International Health, World Health Organization Collaborating Center on Investment for Health and Well-Being, Public Health Wales, Wrexham LL13 7YP, UK
    College of Medicine and Health, Bangor University, Wrexham LL13 7YP, UK)

  • Olumide Adisa

    (Institute of Social Justice and Crime, University of Suffolk, Ipswich IP4 1QJ, UK)

  • Kat Ford

    (College of Medicine and Health, Bangor University, Wrexham LL13 7YP, UK)

Abstract

Violence has immediate and long-term repercussions for the health of individuals and communities. Recent increases in the understanding of public health approaches to violence prevention have focused on the policies and practices of government, health, and other public sector agencies. However, the roles of commercial bodies in fostering and preventing violence remain largely unaddressed. The wealth and influence of some companies now exceeds that of many countries. Consequently, it is timely to explore the roles of commercial processes in violence. Using a conceptual framework for the commercial determinants of health, we examine seven practices: political; scientific; marketing; supply chain and waste; labor and employment; financial; and reputational management. We include areas directly linked with violence (e.g., firearms) and those that indirectly impact violence through the following: design and promotion of products; employment practices; and impacts on environment, poverty, and local resources. A range of avoidable commercial behaviors are found to increase levels of violence including the following: lobbying practices; distortion of scientific processes; polluting manufacture and supply lines; poor employee protections; financial investment in organizations and regimes associated with violence; and misleading communications and marketing. We conclude commercial actors can take action to ensure their workers, clients, suppliers, and distributors help prevent, not promote, violence. New technologies such as artificial intelligence are transforming corporate processes and products and offer opportunities to implement violence prevention through commercial developments (e.g., monitoring online content). International regulation of commercial behaviors is needed to prevent interpersonal and interstate conflict and harms to health and trade.

Suggested Citation

  • Mark A. Bellis & Sally McManus & Karen Hughes & Olumide Adisa & Kat Ford, 2024. "The Commercial Determinants of Violence: Identifying Opportunities for Violence Prevention through a Public Health-Based Framework Analysis," IJERPH, MDPI, vol. 21(3), pages 1-18, March.
    • Handle: RePEc:gam:jijerp:v:21:y:2024:i:3:p:352-:d:1357921
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/21/3/352/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/21/3/352/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Robin Roslender, 2023. "The spread of sportswashing within top-flight football: a discussion of its underpinnings, mechanisms and probable consequences," Accounting, Auditing & Accountability Journal, Emerald Group Publishing Limited, vol. 37(2), pages 638-648, July.
    2. Paul B. Tchounwou, 2023. "A New Vision for IJERPH —A Transdisciplinary Journal of Environmental Research and Public Health," IJERPH, MDPI, vol. 20(18), pages 1-3, September.
    3. S. Sethi & Donald Schepers, 2014. "United Nations Global Compact: The Promise–Performance Gap," Journal of Business Ethics, Springer, vol. 122(2), pages 193-208, June.
    4. Van Zee, A., 2009. "The promotion and marketing of oxycontin: Commercial triumph, public health tragedy," American Journal of Public Health, American Public Health Association, vol. 99(2), pages 221-227.
    5. Strycharz, Joanna & Duivenvoorde, Bram Benjamin, 2021. "The exploitation of vulnerability through personalised marketing communication: Are consumers protected?," Internet Policy Review: Journal on Internet Regulation, Alexander von Humboldt Institute for Internet and Society (HIIG), Berlin, vol. 10(4), pages 1-27.
    6. Lauren M. Ross & Gregory D. Squires, 2011. "The Personal Costs of Subprime Lending and the Foreclosure Crisis: A Matter of Trust, Insecurity, and Institutional Deception," Social Science Quarterly, Southwestern Social Science Association, vol. 92(1), pages 140-163, March.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Louis‐Philippe Beland & Jason Huh & Dongwoo Kim, 2024. "The effect of opioid use on traffic fatalities," Health Economics, John Wiley & Sons, Ltd., vol. 33(6), pages 1123-1132, June.
    2. Vásquez-Vera, Hugo & Palència, Laia & Magna, Ingrid & Mena, Carlos & Neira, Jaime & Borrell, Carme, 2017. "The threat of home eviction and its effects on health through the equity lens: A systematic review," Social Science & Medicine, Elsevier, vol. 175(C), pages 199-208.
    3. Marcelo Royo-Vela & Jonathan Cuevas Lizama, 2022. "Creating Shared Value: Exploration in an Entrepreneurial Ecosystem," Sustainability, MDPI, vol. 14(14), pages 1-23, July.
    4. William Encinosa & Didem Bernard & Thomas M. Selden, 2022. "Opioid and non-opioid analgesic prescribing before and after the CDC’s 2016 opioid guideline," International Journal of Health Economics and Management, Springer, vol. 22(1), pages 1-52, March.
    5. Alice Hengevoss, 2021. "Assessing the Impact of Nonprofit Organizations on Multi-Actor Global Governance Initiatives: The Case of the UN Global Compact," Sustainability, MDPI, vol. 13(13), pages 1-13, June.
    6. Abhimanyu Sud & Darren K. Cheng & Rahim Moineddin & Erin Zlahtic & Ross Upshur, 2021. "Time series-based bibliometric analysis of a systematic review of multidisciplinary care for opioid dose reduction: exploring the origins of the North American opioid crisis," Scientometrics, Springer;Akadémiai Kiadó, vol. 126(11), pages 8935-8955, November.
    7. Heloïse Berkowitz & Marcelo Bucheli & Hervé Dumez, 2017. "Collectively Designing CSR Through Meta-Organizations: A Case Study of the Oil and Gas Industry," Journal of Business Ethics, Springer, vol. 143(4), pages 753-769, July.
    8. Elisa Giuliani & Federica Nieri & Andrea Vezzulli, 2019. "BEST IN CLASS BUT BIG WRONGDOERS: Exploring the financial performance and human rights infringe ments nexus in large emerging country companies," Discussion Papers 2019/250, Dipartimento di Economia e Management (DEM), University of Pisa, Pisa, Italy.
    9. Andreas Rasche & Wencke Gwozdz & Mathias Lund Larsen & Jeremy Moon, 2022. "Which firms leave multi‐stakeholder initiatives? An analysis of delistings from the United Nations Global Compact," Regulation & Governance, John Wiley & Sons, vol. 16(1), pages 309-326, January.
    10. Ravi Katari, Dean Baker, 2015. "Patent Monopolies and the Costs of Mismarketing Drugs," CEPR Reports and Issue Briefs 2015-11, Center for Economic and Policy Research (CEPR).
    11. Johanna Catherine Maclean & Justine Mallatt & Christopher J. Ruhm & Kosali Simon, 2022. "The Opioid Crisis, Health, Healthcare, and Crime: A Review of Quasi-Experimental Economic Studies," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 15-49, September.
    12. McGranahan, David A. & Parker, Timothy S., 2021. "The Opioid Epidemic: A Geography in Two Phases," USDA Miscellaneous 310390, United States Department of Agriculture.
    13. Deiana, Claudio & Giua, Ludovica & Nistico, Roberto, 2019. "The Economics behind the Epidemic: Afghan Opium Price and Prescription Opioids in the US," IZA Discussion Papers 12872, Institute of Labor Economics (IZA).
    14. Anne Case & Angus Deaton, 2017. "Mortality and Morbidity in the 21st Century," Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 48(1 (Spring), pages 397-476.
    15. James F. Anderson & Kelley Reinsmith-Jones & Willie M. Brooks, Jr. & Adam H. Langsam, 2017. "Paradigm Shift in Responding to Drug Users and Addicts: From a Criminal Justice to a Public Health Approach," International Journal of Social Science Studies, Redfame publishing, vol. 5(5), pages 1-15, May.
    16. Damian Bäumlisberger, 2019. "The United Nations Global Compact as a Facilitator of the Lockean Social Contract," Journal of Business Ethics, Springer, vol. 159(1), pages 187-200, September.
    17. Kenneth E. Goodpaster & T. Dean Maines & Michael Naughton & Brian Shapiro, 2018. "Using UNPRME to Teach, Research, and Enact Business Ethics: Insights from the Catholic Identity Matrix for Business Schools," Journal of Business Ethics, Springer, vol. 147(4), pages 761-777, February.
    18. Shannon M. Monnat, 2022. "Demographic and Geographic Variation in Fatal Drug Overdoses in the United States, 1999–2020," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 50-78, September.
    19. Boslett, Andrew & Hill, Elaine, 2022. "Mortality during resource booms and busts," Journal of Environmental Economics and Management, Elsevier, vol. 115(C).
    20. McGranahan, David & Parker, Timothy, 2021. "The Opioid Epidemic: A Geography in Two Phases," Economic Research Report 327197, United States Department of Agriculture, Economic Research Service.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:21:y:2024:i:3:p:352-:d:1357921. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.